{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:06:35Z","timestamp":1786975595061,"version":"build-2736575974"},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2023,11,1]]},"DOI":"10.1001\/jamadermatol.2023.3846","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:01:45Z","timestamp":1697626905000},"page":"1177","source":"Crossref","is-referenced-by-count":11,"title":["Dupilumab, Atopic Dermatitis, and Mycosis Fungoides\u2014New Insights on an Evolving Story"],"prefix":"10.1001","volume":"159","author":[{"given":"Joan","family":"Guitart","sequence":"first","affiliation":[{"name":"Department of Dermatology, Northwestern University Feinberg Medical School, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"ded230018r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.3849","article-title":"Dupilumab-associated lymphoid reactions in patients with atopic dermatitis.","author":"Boesjes","journal-title":"JAMA Dermatol"},{"key":"ded230018r2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/nyas.2001.941.issue-1","article-title":"The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.","volume":"941","author":"Berger","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"ded230018r3","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1080\/10428190410001693560","article-title":"Cutaneous T-cell lymphoma: a paradigm for biological therapies.","volume":"45","author":"Pichardo","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"ded230018r4","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000095044","article-title":"Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitis.","volume":"213","author":"Mougel","year":"2006","journal-title":"Dermatology"},{"issue":"18","key":"ded230018r5","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1182\/blood-2014-07-590398","article-title":"Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.","volume":"125","author":"Geskin","year":"2015","journal-title":"Blood"},{"issue":"1","key":"ded230018r6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/bjd\/ljad072","article-title":"Malignancy risk in patients with atopic dermatitis: a population-based cohort study.","volume":"189","author":"Wan","year":"2023","journal-title":"Br J Dermatol"},{"issue":"2","key":"ded230018r7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"ded230018r9","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jaad.2022.12.001","article-title":"Diagnosis of mycosis fungoides or S\u00e9zary syndrome after dupilumab use: A systematic review.","volume":"88","author":"Jfri","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"ded230018r10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jaad.2020.03.050","article-title":"Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients.","volume":"83","author":"Espinosa","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"ded230018r11","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.12788\/cutis","article-title":"Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma.","volume":"106","author":"Hollins","year":"2020","journal-title":"Cutis"},{"issue":"3","key":"ded230018r12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.12788\/cutis","article-title":"Cutaneous T-cell lymphoma and concomitant atopic dermatitis responding to dupilumab.","volume":"106","author":"Mollanazar","year":"2020","journal-title":"Cutis"},{"issue":"6","key":"ded230018r13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jamadermatol.2023.0627","article-title":"Efficacy and safety of tralokinumab in adolescents with moderate to severe atopic dermatitis: the phase 3 ECZTRA 6 randomized clinical trial.","volume":"159","author":"Paller","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"4","key":"ded230018r14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamadermatol.2020.0079","article-title":"Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: a phase 2b randomized clinical trial.","volume":"156","author":"Guttman-Yassky","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"24","key":"ded230018r15","doi-asserted-by":"publisher","first-page":"13388","DOI":"10.3390\/ijms222413388","article-title":"Safety and danger considerations of novel treatments for atopic dermatitis in context of primary cutaneous lymphomas.","volume":"22","author":"Kolkowski","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ded230018r8"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2810842\/jamadermatology_guitart_2023_ed_230018_1699989225.29355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:02:30Z","timestamp":1700046150000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2810842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2023.3846","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}